Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00671788
Brief Title: A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

First Submitted : May 2, 2008
First Submitted that Met QC Criteria : May 2, 2008
First Posted : May 5, 2008 (Estimate)

Results First Submitted : January 31, 2014
Results First Submitted that Met QC Criteria : June 17, 2014
Results First Posted : July 18, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 17, 2016
Last Update Posted : April 15, 2016 (Estimate)